Trial Profile
Phase I study investigating the pharmacokinetic impact of delayed administration of USL255
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2014
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- 06 Jun 2014 New trial record
- 10 Dec 2013 According to a Upsher-Smith media release, the results of this trial have been presented at American Epilepsy Society's (AES) 67th Annual Meeting.